SUMMARY The effects of procedures believed to produce a decrease in serum ionized calcium were tested on visual and oculomotor function in nine multiple sclerosis (MS) patients. Transient improvement in scotomas, nystagmus, and oculomotor paresis occurred with intravenous infusions of NaHCO3 or Na2EDTA. Hyperventilation was also tested for its effect on nystagmus and caused marked decreases in frequency. Control experiments with saline infusions did not produce any effect. The probable mechanism and site of action for these effects is discussed. This study demonstrates that certain signs and symptoms in MS can be altered favourably by changes in the internal chemical environment and offers a new approach to the search for a symptomatic therapy in MS.
Multiple sclerosis (MS) is a disease affecting the white matter of the central nervous system. It is characterized pathologically by numerous discrete areas of myelin loss along the course of involved axons. These demyelinated lesions are believed to cause a slowing and block of conduction which in turn is responsible for the clinical signs (Charcot, 1877; Namerow, 1968a; Namerow and Kappl, 1969) .
There is reason to believe that this axonal conduction defect is labile and capable of being modified in both a favourable and unfavourable manner. This is suggested by the remarkable fact that small changes in body temperature can markedly alter specific signs in MS (Simons, 1937; Brickner, 1950; Guthrie, 1951; Edmund and Fog, 1955; Nelson, Jeffreys, and McDowell, 1958; Boynton, Garramone, and Buca, 1959; Nelson and McDowell, 1959; Watson, 1959) . Heating and cooling cause a transient worsening and improvement respectively. A recent report described an MS patient with optic nerve involvement whose visual acuity decreased from 5/40 to 5/200 after only a 0-25°C temperature rise (Namerow, 1968b) . These effects only last as long as the temperature change is maintained. They are not specific for MS, since other neurological diseases are aggravated by hyperthermia. However, they clearly occur with greater frequency and sensitivity in MS (Nelson et al., 1958; Nelson and McDowell, 1959; Namerow, 1968b) .
Since an understanding of these temperature effects (especially that of cooling) might reveal a rational basis for a symptomatic treatment in MS, earlier studies were aimed at developing a simple but pertinent conduction model. Studies in a variety of animals-frog (Davis, 1969) , lobster (Davis, 1970) , guinea-pig (Davis and Jacobson, 1970) -have demonstrated that demyelinated and injured nerves have a heightened sensitivity to reversible thermal block-that is, conduction fails at temperatures within or close to the physiological range. Conversely, it has been shown that cooling restores conduction in injured nerves (Davis, 1970) . It has been postulated that these effects are related to critical alterations in the conduction safety factor (Davis, 1970) . The safety factor is defined as the ratio of the action current of a nerve fibre to the minimum current necessary to maintain conduction (Tasaki, 1953) . This ratio reflects the net effect of many variables involved in the maintenance of axonal conduction. Tasaki found a value of 5 to 7 for the safety factor in amphibian myelinated nerve (Tasaki, 1953 (Misske, 1930; Brink, Bronk, and Larrabee, 1946) . Since this would decrease the minimum current needed to maintain conduction, it should increase the safety factor. In support of this, it has been demonstrated that conduction block in injured nerve is reversed by lowering the concentration of calcium ions in the bathing medium (Davis, 1969) .
In this paper we report the effect on visual and oculomotor defects in MS of three procedures believed to lower serum ionized calcium. It has been found that infusions of sodium bicarbonate (NaHCO3) and sodium edetate (Na2EDTA) as well as hyperventilation improve clinical findings in MS. This study was, in part, previously reported in a brief preliminary communication (Davis, Becker, Michael, and Sorensen, 1970 Eye movements were recorded electro-oculographically (Shackel, 1960) using gold surface electrodes (Beckman E5G) placed at the canthi of each eye. Two AC-coupled amplifiers (bandpass 0-10,000 Hz, gain of 1,000) were used to increase the signal levels of the corneoretinal potential of each eye.
Subjects were instructed to maintain fixation on the light that was lit, and told to look 'left' or 'right' as the lights were turned on and off. Thus, an alternating pattern of left lateral, central, and right lateral gaze was elicited with nystagmus appearing during periods of lateral gaze. The duration of fixation at any position varied from 10 to 25 seconds. At the beginning of each experiment a 2 to 3 minute control run was obtained. The procedure to be tested was then begun and nystagmus was monitored periodically throughout the experiment.
Quantitative measurements were obtained by determining the frequency of nystagmus; the use of ACcoupled amplifiers and the usual long-term changes in electrode impedance made it difficult to monitor the amplitude of nystagmus quantitatively in a systematic way.
With the movements of both eyes being monitored independently and with nystagmus often appearing on both left and right lateral gaze, four possible measurements were obtainable. The quality of the records for each eye was rarely equal because of differences of electrode impedance and the noise characteristics of each recording channel, as well as the fact that nystagmus was sometimes more marked in one eye, usually the abducting eye. Because of this, the particular record with the highest signal-to-noise ratio was selected for quantitative analysis. Thus, in each experiment the nystagmus of one eye in one particular direction of lateral gaze is consistently reported. This was acceptable since the changes in nystagmus on conjugate gaze were qualitatively similar in both eyes with all the experimental procedures.
CHEMICAL DETERMINATIONS Total serum calcium was determined by means of the EDTA titration technique (Bett and Fraser, 1959) and also by the fluorometric method (Jackson, Breen, and Chen, 1962) during the Na2EDTA infusions. Ultrafiltrable calcium was obtained by the technique of Toribara (Toribara, Terepka, and Dewey, 1957) . The ionized calcium was approximated during an Na2EDTA infusion experiment by determining the calcium in the ultrafiltrate by the EDTA titration method. This value represents the non-EDTA-complexed calcium in the ultrafiltrate, which is mainly in the ionized form, but also includes small amounts of complexed calcium not bound to EDTA.
RESULTS
VISUAL STUDIES Infusions of NaHCO3 and Na2EDTA each resulted in marked decreases in the size of visual scotomas. The effect appears gradually within an hour after starting an infusion and slowly reverses within a similar period of time after infusion. Figure 1 shows a typical experiment with NaHCO3. Table 3 . Though no change occurs during the saline infusion there is a prompt response on switching to NaHCO3 which was heated to 990 F (37-2°C)-that is, the temperature of NaHCO3 at the site of the intravenous hypodermic needle. Thus, the effect is not simply due to a non-specific body cooling caused by the infusion. Also, a decrease in scotoma size did not occur with 10% glucose. The experiment shown in Table 4 and Fig. 3 tests the hypothesis that the NaHCO3 effect is related to alterations in blood calcium. Two infusions were started in separate arms. NaHCO3 was infused first and, when the scotoma had shown a clear-cut decrease in size, an infusion of calcium chloride was started in the other arm. Note the return of the scotoma to control size while both NaHCO3 and calcium chloride infusions are running simultaneously.
In every NaHCO3 and Na2EDTA infusion, patients reported paraesthesias. These were most marked around the mouth and/or distally in the limbs. These usually preceded the changes in scotomas (and nystagmus).
NYSTAGMUS STUDIES The effect of 2 to 3 minutes hyperventilation on nystagmus was tested in six patients. A total of 13 separate experiments were performed (Table 5 ) and in each case similar alterations were noted. In nine experiments in which eye movements were recorded electro-oculographically there was a 33 to 100% decrease in nystagmus frequency. These effects begin as early as 1 minute after starting hyperventilation and, as seen in Table  5 , reach maximum values before 3 minutes; the effect is rapidly reversible. An example of an eye movement recording with hyperventilation is shown in Fig. 4 . Figure 5 (top) shows the typical time course of the nystagmus change from onset to recovery.
Since a lowering of body temperature improves nystagmus in MS, the question was raised whether the decrease in nystagmus frequency with hyperventilation might be due entirely to a cooling effect related to the rapid exchange of the cooler room air. That this was not the case was established by the following experiment.
The patient (R.W.) breathed air that had been either heated or cooled by passing it through a heat exchanger; the temperature of the inspired air was monitored with a thermistor probe and a Yellowsprings Instrument thermometer. It was discovered that lowering the air temperature, during quiet breathing (not hyperventilation) produced a decrease in the frequency of nystagmus. A decrease in nystagmus frequency occurred from 3 0 beats/sec with air at 80°F (26-7°C) to 2-3 beats/sec with air at 75°F (23-9°C) (23 % decrease). On a second trial lowering the temperature from 78-80F (26°C) to 71 50F (22°C) lowered the frequency from 2-8 beats/sec to 1-9 beats/sec (32 % decrease). In another experiment seven days later, it was observed that heating air NaHCO. However, with a nystagmus frequency of 2-7 three patie beats/sec, while breathing air at 100 8°F (38 2°C) creases in i (not hyperventilation) the subject was instructed to experiment hyperventilate, and within 3 minutes the nystagmus the frequer disappeared. Thus, although increased inspired air seen in Fig   FIG. 3 . Scotoma plotted with a 1 mm red target. Control (upper left); during NaHCO3 infusion (upper middle and right); after switching to simultaneous infusions of NaHCO3 and CaCl2 (bottom row). The decrease in scvtoma size seen with NaHCO3 is inhibited by CaCI2.
re increased the control level of nystagmus, lation still caused a cessation of nystagmus. ,e conditions (air temperature greater than perature) hyperventilation is not at all roduce a cooling effect. I, and Na3EDTA infusions were given to ents, all of whom showed marked denystagmus frequency. The results of five ts are given in Table 6 . The time course of ncy change in two typical experiments is ;. 5 (centre and bottom). No effects were During the NaHCO, infusion the two images gradually came together and then fused into a single image; at the time of fusion the adduction weakness was no longer clinically discernible. Shortly after stopping the infusion the adduction weakness again became evident and diplopia returned. On restarting the NaHCO3 infusion the same effects were again observed.
CHEMICAL STUDIES Table 7 summarizes the changes in blood chemistry measured during some of the experimental procedures. Hyperventilation in one patient produced a respiratory alkalosis with an arterial pH of 7 67. NaHCO3 produced the expected metabolic alkalosis with CO2 values rising as high as 43 m-equiv/l. During the NaHCO3 infusions decreases in total calcium were small varying from 0-3-1 3 mg/100 ml. and lesser decreases occurred in ultrafiltrable calcium (02-0-8 mg/100 ml.) The Na2EDTA infusion produced a 21 mg/100 ml. infusions of NaHCO3 and Na2EDTA. Since these effects do not occur with normal saline infusions given at room temperature and since solutions of NaHCO heated to 99°F are effective, the phenomenon cannot be due to a non-specific body cooling caused by the infusion. In the case of hyperventilation a cooling effect has also been ruled out, since the change in nystagmus occurs even when the inspired air is heated to 100-80F (38-2°C). It is therefore concluded that the effect is due to a more specific alteration in the internal environment. Before discussing this particular aspect further, the probable site of action of this alteration will be considered. While the changes in nystagmus could be due to an effect on the central and/or peripheral nervous system (brain, cranial nerve, neuromuscular junction, muscle) the improvement in the scotomas is most likely due to an effect on the central nervous system since the neural components of vision are all central structures. Since refractive changes might be important these were looked for but none was found.
HV PRE-HV
A scotoma is classified as a negative sign, in that it reflects a diminution or absence of function. In MS it is caused by a demyelinating lesion(s) in the optic nerve which results in an impairment of axonal conduction. The marked decrease in the size of scotomas seen with NaHCO3 and Na2EDTA infusions suggests that an improvement of conduction has occurred in these diseased axons. That is, the scotoma changes would appear to be due to an effect within the central nervous system probably occurring at the region of the demyelinated lesion and resulting in an improvement of axonal conduction. Although a similar mechanism might be operating for the changes seen in nystagmus, it is important to keep in mind that, unlike scotomas, its pathophysiological basis is unknown and thus any hypothesis must be considered with caution.
The improvement in clinical findings in MS with hyperventilation, NaHCO5 and Na2EDTA is probably due, at least in part, to a lowering of serum ionized calcium, which increases axonal excitability and in turn produces an increase in the conduction safety factor. There is evidence for a formidable blood-CSF barrier to calcium in normals (Soffer and Toribara, 1961; Schain, 1964) , multiple sclerosis patients (Merritt and Bauer, 1931) , and patients with disorders of calcium metabolism (Hebert, 1933) . However, it is conceivable that there is a localized breakdown of the blood-brain barrier to calcium at the site of MS plaques which might not produce a marked change in CSF calcium. This is supported by the finding of Broman (Broman, 1944) that increased uptake of trypan blue occurs in MS plaques. Thus, a low serum ionized calcium might alter brain calcium in MS where it counts most-that is, at the site of the demyelinating lesion. This idea of a breakdown in the blood-brain barrier for calcium is also sup-ported by our experimental observation that the decrease in scotoma size with an infusion ofNaHCO3 is reversed by a simultaneous infusion of calcium chloride. Though this is probably due to the correction of the induced hypocalcaemia, another possibility is that a transient hypercalcaemic state induced by the CaCl2 infusion caused a depression of nerve excitability.
It is well known that hyperventilation (Fanconi and Rose, 1958) , NaHCO3 (Moore, 1970) and Na2EDTA (Soffer and Toribara, 1961) N6, 1947) . Since CO2 readily passes the blood-brain barrier the central decrease in pCO2 with hyperventilation might add to the enhancement of the safety factor. In the case of Na2EDTA the possibility that it can pass the blood-brain barrier in MS patients must also be considered; available evidence suggests that it does not pass the blood-CSF barrier in normal man (Soffer and Toribara, 1961) . The pH itself may also have a direct effect on conduction. Lorente de N6 found no significant changes over wide ranges in excised frog nerve (Lorente de No, 1947) , but in the squid giant axon increases in the internal or external pH tend to enhance excitability (Tasaki, Singer, and Takenaka, 1964) . Another factor, especially with the sodium bicarbonate infusion, may be an increase in serum sodium concentration which might increase the amplitude of the action potential (Hodgkin and Katz, 1949) . All of these changes could enhance the conduction safety factor.
Although the preceding theoretical considerations may require modifications when more data are available, the phenomena described in this paper indicate that clinical signs in MS can be improved by chemical means. The implication seems clear that a search for effective drugs is warranted. Based on the proposed mechanisms, a reasonable approach would be to screen carefully drugs which might enhance the conduction safety factor. Theoretically some of the veratrum alkaloids which prolong the action potential duration and produce a decreased threshold for stimulation might be effective (Goodman and Gilman, 1965) . These studies are in progress.
